文献速递头颈部肿瘤放疗放疗物理与技术

DKK1通过诱导放疗和免疫治疗抵抗影响头颈部鳞状细胞癌患者的生存

DKK1 affects survival of patients with head and neck squamous cell carcinoma by inducing resistance to radiotherapy and immunotherapy.
PubMed 文献 · Radiother Oncol · 2023-01-20

该研究利用TCGA和GEO数据库分析头颈部鳞状细胞癌(HNSC)中DKK1的表达与生存关系,并通过siRNA沉默DKK1的HSC-3和CNE-2细胞进行放疗敏感性体外实验。结果显示DKK1在HNSC中高表达并与患者生存时间相关,沉默DKK1后细胞活力及集落形成下降、凋亡率增加,DKK1高表达肿瘤呈免疫抑制微环境,提示DKK1是放疗免疫治疗的潜在靶点。

要点

  • DKK1在HNSC中显著高表达,且与患者生存时间密切相关,尤其在接受放疗的患者中。
  • 沉默DKK1的HSC-3或CNE-2细胞经辐射后细胞活力和集落形成下降、凋亡率增加。
  • DKK1高表达肿瘤呈更免疫抑制的微环境,T细胞浸润较低而髓源性抑制细胞(MDSC)浸润较高。

核心结论

  • DKK1可同时影响HNSC的放疗和免疫治疗,提示DKK1可能是HNSC放疗免疫治疗的潜在靶点。

研究设计与样本

  • 从TCGA和GEO数据库收集HNSC患者的基因表达谱和临床信息进行分析。
  • 使用R包CIBERSORT和ESTIMATE评估免疫细胞浸润和免疫评分,GSEA分析相关通路和生物学过程,GSVA计算感兴趣基因集的标签评分。
  • 通过siRNA沉默DKK1后,对HSC-3细胞和CNE-2细胞进行细胞活力和凋亡实验及克隆形成实验,以研究辐射敏感性。

主要发现

  • DKK1在HNSC中显著高表达,并与患者生存时间密切相关,尤其是接受放疗的患者。
  • 沉默DKK1的HSC-3细胞或CNE-2细胞经辐射后细胞活力和集落形成下降、凋亡率增加。
  • DKK1高表达肿瘤显示更免疫抑制的微环境,T细胞浸润较低而髓源性抑制细胞(MDSC)浸润较高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immune checkpoint inhibitors (ICIs) have been approved to treat various types of tumors, including head and neck squamous cell carcinoma (HNSC). However, most HNSC patients do not respond to ICIs. Radioimmunotherapy has been proposed to enhance the immune response rate in HNSC. Dickkopf-1 (DKK1), a secreted protein, plays important roles in the Wnt signaling pathways. Herein, we aimed to explore the effect of DKK1 on radioimmunotherapy in HNSC. METHODS: We collected the gene expression profile and clinical information of HNSC patients from TCGA and GEO databases. The immune cell infiltration and immune score were assessed using R package CIBERSORT and ESTIMATE. The level of related pathways and biological processes were analyzed by GSEA. The signature scores of gene sets of interest were calculated by GSVA. We also performed cell viability and apoptosis assay, and clonogenic assay to investigate the radiation sensitivity of HSC-3 cells and CNE-2 cells after silencing DKK1 by siRNA. RESULTS: We found DKK1 was significantly higher expressed in HNSC, and closely correlated with patients' survival time, especially the patients who received radiotherapy. DKK1-knockdown HSC-3 cells or CNE-2 cells showed a decrease in cell viability and colony formation, and an increase in apoptotic rate after radiation. DKK1high tumors showed a more immunosuppressive microenvironment with lower infiltration of T cells and higher infiltration of marrow-derived suppressor cells (MDSCs). CONCLUSION: Our data show that DKK1 can affect both radiotherapy and immunotherapy in HNSC, suggesting that DKK1 can be a potential target for radioimmunology in HNSC.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Ye X, Liu J, Quan R, et al. DKK1 affects survival of patients with head and neck squamous cell carcinoma by inducing resistance to radiotherapy and immunotherapy. Radiother Oncol. 2023. PMID: 36690301. doi:10.1016/j.radonc.2023.109485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。